Indivi
Indivi builds smartphone-based digital biomarkers that quantify cognition, motion, vision, balance, dexterity, and voice to support neurological drug development. The company transforms smartphones into digital measurement laboratories using sensor-derived assessments and validated instruments such as Konectom and dreaMS, delivered via a SaaS plus services model. Its platform combines signal processing, data science, machine learning and AI, and cloud infrastructure, and supports end-to-end clinical trial workflows from protocol design to regulatory reporting. Indivi works primarily with pharmaceutical companies, CROs and academic partners and is ISO 13485:2016 certified for SaMD manufacturing. The product targets neurodegenerative and neurological indications including Parkinson’s, MS, Alzheimer’s and related dementias to de-risk and accelerate clinical development.
Indivi
Indivi builds smartphone-based digital biomarkers that quantify cognition, motion, vision, balance, dexterity, and voice to support neurological drug development. The company transforms smartphones into digital measurement laboratories using sensor-derived assessments and validated instruments such as Konectom and dreaMS, delivered via a SaaS plus services model. Its platform combines signal processing, data science, machine learning and AI, and cloud infrastructure, and supports end-to-end clinical trial workflows from protocol design to regulatory reporting. Indivi works primarily with pharmaceutical companies, CROs and academic partners and is ISO 13485:2016 certified for SaMD manufacturing. The product targets neurodegenerative and neurological indications including Parkinson’s, MS, Alzheimer’s and related dementias to de-risk and accelerate clinical development.
TL;DR
What they do: Smartphone-based digital biomarkers and endpoint platform for neurological drug development
Headquarters & founding: Basel, Switzerland; founded 2012
Key products: dreaMS (CE-marked app for MS) and Konectom™ platform
Customers: Pharmaceutical companies, CROs, academic partners
Regulatory / quality: ISO 13485:2016 certified; dreaMS is CE-marked